Provided by Tiger Trade Technology Pte. Ltd.

IMMUNOTECH-B

0.390
+0.0051.30%
Volume:292.00K
Turnover:115.25K
Market Cap:241.02M
PE:-0.80
High:0.410
Open:0.370
Low:0.370
Close:0.385
52wk High:5.830
52wk Low:0.330
Shares:618.00M
HK Float Shares:618.00M
Volume Ratio:1.47
T/O Rate:0.05%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.490
ROE:-242.61%
ROA:-18.75%
PB:-14.83
PE(LYR):-0.80
PS:- -

Loading ...

Expert Analysis: Guotai Fund's Qiu Xiaoxu Says Innovation Drug Exports Remain Strong, Three Investment Themes to Guide Healthcare Sector Strategy

Deep News
·
Aug 07

China A-Share Noon Wrap: Three Major Indices Edge Higher; PCB and Innovative Drug Stocks Surge, Over 3,000 Stocks Decline

Stock News
·
Aug 07

Hong Kong Market Movers: Innovative Drug Stocks Rally as Earnings Season Approaches, Medical Conferences Expected to Provide Catalysts

Stock News
·
Aug 07

Positive Catalysts Drive Surge in Innovative Drug Sector; WuXi Series Leads as Huabao's Hong Kong Stock Connect Medical ETF Jumps 3%

Deep News
·
Aug 07

Innovation in Biotech: Synthetic Biology, Equipment Localization, and New Growth Paths for Chinese Pharma Equipment

Deep News
·
Aug 06

Investment Outlook from IT Expert: Bullish Momentum for Innovative Drugs and Their Supply Chain in Second Half of the Year

Deep News
·
Aug 06

Renewed Momentum in Innovative Drugs: Fleeting Sentiment or Confirmation of an Industry Turning Point?

Deep News
·
Aug 06

Haisco Pharmaceutical Wins Approval for New Migraine Drug Trial

Stock News
·
Aug 06

Building a Layered Coordination System Between Social and Commercial Insurance to Solve Innovative Drug Payment Challenges

Deep News
·
Aug 06

HENGRUI PHARMA's Zhang Lianshan: Global Strategy at a Turning Point, Innovative Drug Firms Must Ultimately Go Global Independently

Deep News
·
Aug 06

Medical Insurance Covers 5,890 Drugs, Accelerating Access for Innovative Medicines

Deep News
·
Aug 05

Pharmaceutical Innovation Chain Surges Across the Board; CXO Giant Reports First Half-Year Net Profit Exceeding 10 Billion Yuan, Soaring Over 10% Post-Earnings; Innovative Drug Leader Rebounds, 520880 Rises 2.58% on Volume

Deep News
·
Aug 04

Top-tier financial institutions actively recommend this major biotech stock, with a market cap of 390 billion yuan, as significant positive catalysts emerge

Deep News
·
Aug 03

Immunotech Biopharm posts stable July 2026 share capital at 617.50 million shares; RMB270 million convertibles remain outstanding

Bulletin Express
·
Aug 03

First Half of 2026 Sees Major Surge in Innovative Drug Financing; Hong Kong Stock Connect Innovative Drug ETF Huabao (520880) Trades at Premium Amid Range-Bound Declines, CICC Says Higher Probability of Recovery

Deep News
·
Aug 03

Unraveling the Second Half Investment Strategy for Innovative Drugs: An Analysis by Great Wall Fund Manager Liang Furui

Deep News
·
Jul 31

Bio-Thera Faces Another 300 Million Yuan Loss as Drug Development Costs Strain Cash Reserves

Deep News
·
Jul 31

Hong Kong Stock Movers: Several Innovative Drug Stocks Rally in Afternoon Trading, GENSCRIPT BIO Surges Nearly 8%, REMEGEN Gains Over 4%

Stock News
·
Jul 31

Clinical Progress Accelerates, But Cash Burn Remains the Unanswered Question for 18A Biotech Innovator

Stock News
·
Jul 31

China's domestic innovative drugs set for overseas revenue breakthrough as policy support strengthens

Stock News
·
Jul 31